References
1a
Zupan M.
Stanovnik B.
Tisler M.
J. Org. Chem.
1972,
37:
2960
1b
Stanovnik B.
Urleb U.
Tisler M.
Heterocycles
1985,
23:
2819
1c
Landreau C.
Deniaud D.
Reliquet A.
Meslin J.-C.
Synthesis
2001,
2015
2a
Forfar I.
Jarry C.
Laguerre M.
Léger JM.
Pianet I.
Tetrahedron
1999,
55:
12819
2b
Chaimbault C.
Bosc JJ.
Léger JM.
Négrier P.
Capelle F.
Jarry C.
J. Pharm. Sci.
2000,
89:
1496
3
Abdulla RF.
Brinkmeyer RS.
Tetrahedron
1979,
35:
1675
4
Jarry C.
Golse R.
Panconi E.
Creuzet MH.
Eur. J. Med. Chem.
1986,
21:
138
5a
Sanfilippo PJ.
Urbanski M.
Press JB.
Dubinsky B.
Moore JB.
J. Med. Chem.
1988,
31:
2221
5b
Hirota T.
Sasaki K.
Yamamoto H.
Nakayama T.
J. Heterocycl. Chem.
1991,
28:
257
6
Naulet M.
Filleux ML.
Martin GJ.
Org. Magn. Reson.
1975,
7:
326
7
Experimental Procedure
for Preparation of Compound 4a. A solution of 1a (1.5
g, 6.10 mmol), and β-nitrostyrene (6.10 mmol) in benzene
(60 mL) was heated at reflux for 30 h. The reaction mixture was
then kept at r.t. for 15 h. A yellow solid was obtained which was
removed, washed with chloroform and petroleum ether repeatedly several
times and dried to afford 4a as yellow
crystals (51%): mp 249 °C. IR (KBr):
1615 (C=N) cm-1. 1H
NMR (DMSO-d6): δ = 8.25 (s, 1 H, H-7), 7.44 (m, 5 H, H-Ar.),
7.23 (t, J = 7.65
Hz, 2 H, H-3′ and H-5′), 6.95 (t, J = 7.65 Hz,
1 H, H-4′), 6.71 (d, J = 7.65 Hz,
2 H, H-2′ and H-6′),
5.97 (s, 1 H, H-5), 5.32 (m, 1 H, H-2), 4.23 (dd, J = 11.85
and 1.90 Hz, 1 H, H-3a), 3.97 (dd, J = 8.80 and
3.60 Hz, 1 H, OCH
2a), 3.93
(dd, J = 11.85 and
2.35 Hz, 1 H, H-3b), 3.22 (dd, J = 8.80 and
6.90 Hz, 1 H, OCH
2b). 13C
NMR (DMSO-d6): δ = 162.2 (C-8a), 157.9 (C-1′),
150.5 (C-1′′), 137.9
(C-7), 129.6 (C-3′ and C-5′), 129.1 (C-4′′),
129.0 (C-3′′ and C-5′′), 128.0 (C-2′ and C-6′), 127.0
(C-6), 121.3 (C-4′),
114.5 (C-2′′ and C-6′′), 77.6 (C-2), 67.1 (OCH2),
58.0 (C-5), 45.9 (C-3).
Anal. Calcd for C19H17N3O4:
C, 64.95; H, 4.88; N, 11.96. Found: C, 65.03; H, 4.91; N, 12.07.
X-ray Data: Yellow single crystal (0.40 × 0.15 × 0.10
mm3) of 4a was obtained
by slow evaporation from methanol/chloroform (10/90)
solution: monoclinic, space group P21/c, a = 15.577(5) Å, b = 5.855(1) Å, c = 18.970(3) Å, α = 90°, β = 102°, V = 1692.3(7) Å3,
Z = 4, δ (calcd) = 1.379
Mgm-3, FW = 351.36
for C19H17N3O4, F(000) = 736.
8
Charustin VN.
Van der Plas HC.
Recl. Trav.
Chim. Pays-Bas
1983,
102:
373
9
Thakur AJ.
Saikia P.
Prajapati D.
Sandhu JS.
Synlett
2001,
1299
10 Supplementary X-ray crystallographic
data of compound 4a (CCDC 177408): Cambridge
Crystallographic Data Centre, University Chemical Lab, 12 Union
Road, Cambridge,CB2 1EZ, UK; E-mail : deposit@ccdc.cam.ac.uk.
11a
Gawley RE.
Aubé J. In
Principles of Asymmetric Synthesis
Baldwin JE.
Magnus PD.
Pergamon;
Oxford:
1996.
p.274
11b
Garner P.
Anderson JT.
Turske RA.
Chem. Commun.
2000,
17:
1579
11c
Boger DL.
Corbett WL.
Curran TT.
Kasper AM.
J.
Am. Chem. Soc.
1991,
113:
1713
12 Hyperchem is a product of Hypercube
Media Concepts Inc.
13a
Diaz-Ortiz A.
Carillo JR.
Gomez-Escalonilla MJ.
De la
Hoz A.
Moreno A.
Prieto P.
Synlett
1998,
1069
13b
Diaz-Ortiz A.
Carillo JR.
Cossio FP.
Gomez-Escalonilla MJ.
De la Hoz A.
Moreno A.
Prieto P.
Tetrahedron
2000,
56:
1569